Showing 489 results

Filters Content type: News, Editors' picks Topic: Resistance

Poor adherence and the subsequent development of drug resistance is one reason why HIV treatment can fail. A drug-resistant HIV strain is one which is less susceptible to the effects of one or more anti-HIV drugs.

Sexually transmitted infections prevention

Doxycycline PEP after sex appears ineffective for cisgender women

News
21 February 2023
Sexually transmitted infections prevention

No marked increase in gonorrhoea resistance in doxyPEP study

News
21 February 2023
Injectable & long-acting HIV treatment

FDA Approves New HIV Drug for Adults with Limited Treatment Options

Editor's pick
FDA
22 December 2022
Injectable & long-acting HIV treatment

‘Real world’ injectable treatment halves patient dissatisfaction, with only two viral failures in first six months

News
1 November 2022
Resistance

Low-level HIV and viral load blips are important warning signals, European study finds

News
19 October 2022
Resistance

Are people with a shorter history of viral suppression at greater risk of failure of dolutegravir/lamivudine?

News
6 October 2022
Changing treatment

A Switch to B/F/TAF Keeps HIV Suppressed, Even With Mutation

Editor's pick
Medscape (requires free registration)
20 September 2022
Resistance

HIV patients in Botswana get adequate treatment but not all of them – one group is slipping through the cracks

Editor's pick
The Conversation
6 September 2022
Resistance

Fostemavir Improves Outcomes for Treatment-Resistant HIV Patients

Editor's pick
Contagion Live
1 August 2022
New & experimental HIV treatments

Fostemsavir Plus Optimized Background Therapy May Be Viable for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
30 June 2022
Resistance

Dolutegravir resistance showing up after prolonged periods on failing treatment

News
2 June 2022
HIV treatment for children & young people

High levels of infant resistance to abacavir and tenofovir in Namibia

News
6 May 2022
Antibody-based treatment

Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?

News
23 February 2022
Injectable & long-acting PrEP

Injected PrEP: breakthrough cases could have been detected sooner

News
22 February 2022
HIV treatment for children & young people

Point-of-care viral load tests did not improve viral suppression in Kenyan children

News
16 February 2022
Treatment guidelines

Act now to tackle HIV drug resistance, WHO urges

Editor's pick
Avert
10 January 2022
Treatment simplification strategies

History of drug resistance or virological failure warrants caution when switching to dolutegravir plus lamivudine

News
30 December 2021
Resistance

Antibiotic-resistant strain of gonorrhoea detected in London

Editor's pick
UK Health Security Agency
29 December 2021
Treatment simplification strategies

Implications of historical M184V on use of dual dolutegravir/lamivudine ART

Editor's pick
i-Base
15 November 2021
Resistance

New cases of multi-drug resistant HIV becoming rarer in Europe

News
28 October 2021
Adherence

Dolutegravir-based regimens result in sustained viral suppression, despite lower adherence and treatment interruptions

News
20 August 2021
Resistance

Transmitted Drug Resistance to Tenofovir and Emtricitabine is declining in China

Editor's pick
Infectious Disease Advisor
12 August 2021
PrEP science

PrEP failures in African programmes are rare, but some are happening in people with good adherence

News
21 July 2021
Resistance

Injectable HIV therapy should only be given after a check for innate resistance, French study suggests

News
8 June 2021